Toronto, Ontario (June 25, 2020) – NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) (TSXV: KHV.P) (the “Corporation”) announces the completion of its previously announced “Qualifying Transaction”, as defined under Policy 2.4 of the TSX Venture Exchange (the “Exchange”). The Qualifying Transaction was effected through a reverse takeover structured as a court approved plan of arrangement under Section 182 of the Business Corporations Act (Ontario) (the “Arrangement”) on the terms and conditions set out in the arrangement agreement dated April 24, 2020 (the “Arrangement Agreement”) among the Corporation, 2752695 Ontario Inc. (a wholly-owned subsidiary of the Corporation) and 2576560 Ontario Inc. doing business as NeuPath Health (“2576560”).
For further information on the Qualifying Transaction, please refer to the filing statement of the Corporation dated May 29, 2020 (the “Filing Statement”) filed under the Corporation’s profile on SEDAR at

Click here to see the full PDF Press Release.